二次性甲状腺功能障碍. 副甲状腺功能障碍. 在患有功能衰竭的患者中进行保守的治疗
JAMA
|March 3, 1975
概括
酸结合抗酸剂和碳酸有效地管理了晚期病患者的二次性甲状腺功能障碍. 这种治疗使副甲状腺激素水平正常化,并解决了相关症状和骨疾病.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 内分泌学 在内分泌学.
- 矿物质的新陈代谢.
背景情况:
- 晚期脏疾病往往导致二次性甲状腺功能障碍.
- 系统性表现包括骨疾病和荷尔蒙失衡.
研究的目的:
- 评估酸盐结合剂和口服碳酸在治疗二次性甲状腺功能障碍症中的有效性.
- 评估对血清,,副甲状腺激素和临床症状的影响.
主要方法:
- 治疗3名患有晚期病的患者 (胰岛素清除率4.6-9.1毫升/分钟).
- 使用酸结合抗酸剂和口服碳酸.
- 监测血清,和免疫反应性副甲状腺激素水平.
主要成果:
- 血清和水平保持在正常范围内.
- 二次性甲状腺功能障碍症症状的逐渐消失.
- 观察到骨质炎纤维化的愈合.
- 血清免疫性甲状腺激素度的正常化.
结论:
- 酸结合抗酸剂和口服碳酸在治疗晚期病的二次性甲状腺功能障碍时是有效的.
- 这种治疗方法可以导致症状缓解和生化正常化.
- 证明了成功治疗纤维性骨炎.
相关概念视频
Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Gastritis-II: Pathophysiology
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Acute Pancreatitis II: Clinical Manifestations and Management
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
Chronic Pancreatitis II: Collaborative Care
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
Esophageal Achalasia
Esophageal achalasia is a chronic neurogenic disorder characterized by impaired relaxation of the lower esophageal sphincter (LES) and absent or ineffective peristalsis in the distal esophagus. This leads to a functional obstruction without a physical blockage, despite significant disruption of esophageal motility.EtiologyAchalasia is caused by degeneration of the myenteric (Auerbach's) plexus, specifically the loss of inhibitory ganglion cells that produce vasoactive intestinal peptide (VIP)...
Chronic Pancreatitis II: Pathophysiology
Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...

